Cwm LLC Has $1.07 Million Position in Humana Inc. (NYSE:HUM)

Cwm LLC boosted its stake in shares of Humana Inc. (NYSE:HUM) by 14.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 2,330 shares of the insurance provider’s stock after buying an additional 287 shares during the quarter. Cwm LLC’s holdings in Humana were worth $1,067,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Mariner LLC lifted its holdings in Humana by 2.3% during the 3rd quarter. Mariner LLC now owns 14,119 shares of the insurance provider’s stock worth $6,869,000 after buying an additional 312 shares during the period. Massachusetts Financial Services Co. MA raised its position in shares of Humana by 27.5% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 27,943 shares of the insurance provider’s stock worth $13,595,000 after acquiring an additional 6,034 shares in the last quarter. Silverarc Capital Management LLC bought a new position in shares of Humana in the 3rd quarter worth about $4,865,000. Vest Financial LLC raised its position in shares of Humana by 43.3% in the 4th quarter. Vest Financial LLC now owns 27,993 shares of the insurance provider’s stock worth $12,815,000 after acquiring an additional 8,455 shares in the last quarter. Finally, Artemis Investment Management LLP raised its position in shares of Humana by 9.6% in the 4th quarter. Artemis Investment Management LLP now owns 64,573 shares of the insurance provider’s stock worth $29,563,000 after acquiring an additional 5,672 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Humana

In other Humana news, Director Jorge S. Mesquita bought 545 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were purchased at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the purchase, the director now directly owns 2,578 shares of the company’s stock, valued at $946,358.02. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.32% of the company’s stock.

Humana Price Performance

HUM stock opened at $305.90 on Friday. The company has a market capitalization of $36.86 billion, a P/E ratio of 19.05, a price-to-earnings-growth ratio of 1.82 and a beta of 0.45. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.59 and a current ratio of 1.67. Humana Inc. has a 52-week low of $299.23 and a 52-week high of $541.21. The business has a 50-day simple moving average of $327.77 and a two-hundred day simple moving average of $393.91.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business had revenue of $29.61 billion during the quarter, compared to the consensus estimate of $28.52 billion. During the same quarter in the previous year, the business earned $9.38 EPS. The company’s quarterly revenue was up 10.7% on a year-over-year basis. Research analysts expect that Humana Inc. will post 16.07 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.16%. Humana’s payout ratio is presently 22.04%.

Wall Street Analyst Weigh In

HUM has been the subject of several research analyst reports. Raymond James initiated coverage on Humana in a research report on Friday, March 22nd. They issued a “market perform” rating for the company. Royal Bank of Canada lowered their price objective on Humana from $415.00 to $353.00 and set an “outperform” rating for the company in a research report on Thursday. Stephens lowered their price objective on Humana from $550.00 to $430.00 and set an “overweight” rating for the company in a research report on Friday, January 26th. Truist Financial reaffirmed a “hold” rating and issued a $550.00 target price on shares of Humana in a research report on Friday, January 19th. Finally, Mizuho decreased their target price on Humana from $550.00 to $400.00 and set a “buy” rating for the company in a research report on Friday, January 26th. Eleven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $424.50.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.